US Capital Partners, LLC has been engaged by Midwest BioEnergy, Ltd. as its strategic advisor in the raising of debt and equity project financing of up to $100 million. The financing will include an initial $10 million in corporate financing and up to $20 million in debt and equity financing for a new bio-gas-to-ammonia plant in Monmouth, Illinois, to be developed by the company’s subsidiary Midwest Ammonia, LLC (“Midwest”).

“We are extremely pleased to be taking a strategic investment banking role in this important new clean-tech project, which will reduce carbon emissions and create about 160 jobs in the local community,” said Jeffrey Sweeney, CEO and Managing Director at US Capital Partners. “We look forward to applying our strong focus on strategic, innovative solutions and on speed and excellence of execution to provide best-in-class project financing for Midwest.”

Midwest Ammonia, LLC, a subsidiary of Illinois-based Midwest BioEnergy, Ltd., is a next generation waste-to-value company developing a new plant for turning wastewater treatment gases regulated by federal watchdogs into anhydrous ammonia for use as fertilizer. In collaboration with the City of Monmouth, Illinois, Midwest plans to build the renewable fertilizer plant at the wastewater treatment site north of the town. Monmouth City Council recently approved a bid that puts in motion the new waste-to-value project, which is expected to produce 7,500 st/y of anhydrous ammonia, reduce carbon emissions, and create a new revenue source for the city.

Since 1998, US Capital Partners has been providing prompt, innovative, and reliable financing solutions including lending, equity financing, and debt re-structuring to businesses across the United States and abroad. US Capital Partners is a private investment bank, direct lender, co-lender, and lead financial arranger that specializes in asset-based debt for small to middle-market private and public companies. The company’s innovative approach allows it to provide the best financing available, not only for companies in excellent financial condition, but also for companies that may have been refused credit by traditional lenders.